G. Bureau

Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.

Marianne Paesmans, Jean‐Paul Sculier, P Libert et al. · Journal of Clinical Oncology · 1995 · 393 citations

A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.

Jean Klášterský, Jean‐Paul Sculier, H. Lacroix et al. · Journal of Clinical Oncology · 1990 · 246 citations

Advanced Nsclc, Medicine, Cancer Management +14

Prognostic factors for patients with small cell lung carcinoma

Marianne Paesmans, Jean‐Paul Sculier, J. Lecomte et al. · Cancer · 2000 · 220 citations

Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium.

Jean Klášterský, Jean‐Paul Sculier, G. Bureau et al. · Journal of Clinical Oncology · 1989 · 131 citations

Study Arms, Medicine, Cancer Management +12

Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the european lung cancer working party

Marianne Paesmans, Jean‐Paul Sculier, P Libert et al. · European Journal of Cancer · 1997 · 83 citations

Medicine, Cancer Management, Pathology +8